These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 11585970)

  • 41. A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer.
    Reina JJ; Aparicio J; Salvador J; Pica JM; Rueda A; Lorenzo A; de la Puente CG; Borrega P; Moreno-Nogueira JA
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):339-45. PubMed ID: 12851783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Irinotecan for the treatment of metastatic colorectal cancer].
    Assenat E; Duffour J; Ychou M
    Bull Cancer; 2006 May; 93(5):507-15. PubMed ID: 16777630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New therapeutic options in chemotherapy of advanced colorectal cancer].
    Reimer P; Rückle-Lanz H
    Med Klin (Munich); 2001 Oct; 96(10):593-8. PubMed ID: 11715331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
    Iqbal S; Lenz HJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancer.
    Gennatas C; Michalaki V; Gennatas S; Papalambros E
    Anticancer Res; 2008; 28(3B):1923-6. PubMed ID: 18630482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy for metastatic colorectal cancer.
    Rosales J; Leong LA
    J Natl Compr Canc Netw; 2005 Jul; 3(4):525-9. PubMed ID: 16038643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
    Cunningham D; Coleman R
    Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of colorectal cancer metastasis: the role of chemotherapy.
    Xiong HQ; Ajani JA
    Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.
    Kabbinavar FF; Schulz J; McCleod M; Patel T; Hamm JT; Hecht JR; Mass R; Perrou B; Nelson B; Novotny WF
    J Clin Oncol; 2005 Jun; 23(16):3697-705. PubMed ID: 15738537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Irinotecan in the treatment of colorectal cancer.
    Fuchs C; Mitchell EP; Hoff PM
    Cancer Treat Rev; 2006 Nov; 32(7):491-503. PubMed ID: 16959432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials.
    Goldberg RM; Erlichman C
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):59-63. PubMed ID: 9726093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients.
    Li W; Xu J; Shen L; Liu T; Guo W; Zhang W; Chen Z; Zhu X; Li J
    BMC Cancer; 2014 Dec; 14():986. PubMed ID: 25527007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Setting a new standard--irinotecan (Campto) in the second-line therapy of colorectal cancer: final results of two phase III studies and implications for clinical practice.
    Cunningham D
    Semin Oncol; 1999 Feb; 26(1 Suppl 5):1-5. PubMed ID: 10213008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recent advance in chemotherapy for advanced colorectal cancer].
    Aiba K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy.
    Koukourakis G; Kouloulias V; Zacharias G; Koukourakis M
    J BUON; 2010; 15(4):652-9. PubMed ID: 21229625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Capecitabine plus irinotecan versus 5-FU/leucovorin plus irinotecan in the treatment of colorectal cancer: a meta-analysis.
    Guo Y; Shi M; Shen X; Yang C; Yang L; Zhang J
    Clin Colorectal Cancer; 2014 Jun; 13(2):110-8. PubMed ID: 24461997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy for colorectal cancer.
    Goyle S; Maraveyas A
    Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.
    El-Rayes BF; Zalupski MM; Manza SG; Rusin B; Ferris AM; Vaishampayan U; Heilbrun LK; Venkatramanamoorthy R; Shields AF; Philip PA
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):283-9. PubMed ID: 17429629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.